ACRS vs AAPL · rev $3.6M vs P/E 39, rev $416.16B
Aclaris Therapeutics Inc (ACRS) versus Apple Inc (AAPL) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
Apple Inc (AAPL) is a consumer electronics company listed on US. It is led by Timothy D. Cook.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
Latest reported AAPL revenue for 2025-09-27 was $416.16B. Net income was $112.01B. Revenue was up 6.4% from 2024-09-28 to 2025-09-27. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
ACRS currently screens at market cap $615.9M. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
Not investment advice. Open the ACRS and AAPL stock pages for the full models.
Not investment advice.